1. Home
  2. INVE vs NYXH Comparison

INVE vs NYXH Comparison

Compare INVE & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$4.01

Market Cap

115.7M

Sector

Technology

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.45

Market Cap

126.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
NYXH
Founded
1990
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.7M
126.0M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
INVE
NYXH
Price
$4.01
$1.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.50
$9.33
AVG Volume (30 Days)
127.7K
35.7K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,219,000.00
N/A
Revenue This Year
$22.10
$213.98
Revenue Next Year
$20.74
$126.25
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$3.08
$2.68
52 Week High
$5.30
$8.59

Technical Indicators

Market Signals
Indicator
INVE
NYXH
Relative Strength Index (RSI) 44.07 19.11
Support Level $3.17 N/A
Resistance Level $4.07 $5.02
Average True Range (ATR) 0.19 0.16
MACD -0.01 -0.09
Stochastic Oscillator 42.97 4.35

Price Performance

Historical Comparison
INVE
NYXH

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: